Open Access. Powered by Scholars. Published by Universities.®
Articles 1 - 1 of 1
Full-Text Articles in Psychiatry and Psychology
Does The Use Of Docosahexaenoic Acid (Dha) Supplementation Decrease The Rate Of Cognitive Decline, As Measured By The Adas-Cog Scale, For Patients With Alzheimer’S Disease?, Erin C. Nakamura
PCOM Physician Assistant Studies Student Scholarship
Objective: The objective of this selective EBM review is to determine whether or not “Does the use of docosahexaenoic acid (DHA) supplementation decrease the rate of cognitive decline, as measured by the ADAS-Cog scale, for patients with Alzheimer’s Disease?”
Study Design: A systematic review of three randomized controlled trials (RCTs) published between 2010 and 2018.
Data Sources: All three RCTs were published in English into peer reviewed journals and discovered via PubMed. The studies were selected based on relevance and ability to answer the clinical question.
Outcome Measured: Cognitive function is the outcome measured using the Alzheimer Disease Assessment Scale- …